DRUG · Unmapped registry intervention
Methotrexate (Metoject® prefilled pen)
Find medicine records ·
Find other trials using this name
Clinical trial
Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient
NCT01871961
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedEvaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Rheumatoid Arthritis (RA)unresolved
Interventions
Sponsors & collaborators
medac GmbHlead sponsor
PPD Development, LPcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01871961 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.